Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease
Lihua Wang(Affiliated Hospital of Hebei University), Carlos Cruchaga(Washington University in St. Louis)
Cited by 53
Related Papers
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Neuroinflammation in Alzheimer disease
|Nature reviews. Immunology|2024|401
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
|Nature Medicine|2021|365
Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease
|JAMA Neurology|2016|189
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
|Nature Medicine|2023|172